Cross Country Healthcare, Inc.
CCRN
$14.13
-$0.13-0.91%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -33.46% | -35.18% | -35.11% | -32.73% | -28.04% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -33.46% | -35.18% | -35.11% | -32.73% | -28.04% |
Cost of Revenue | -31.83% | -33.99% | -34.17% | -32.24% | -27.98% |
Gross Profit | -39.11% | -39.31% | -38.36% | -34.45% | -28.24% |
SG&A Expenses | -19.08% | -17.22% | -14.84% | -15.74% | -5.87% |
Depreciation & Amortization | -0.80% | 7.58% | 16.93% | 22.52% | 45.89% |
Other Operating Expenses | 7,772.00% | -- | -- | -- | -- |
Total Operating Expenses | -29.32% | -31.00% | -30.89% | -29.54% | -24.68% |
Operating Income | -100.62% | -91.41% | -84.25% | -65.71% | -58.25% |
Income Before Tax | -115.94% | -99.64% | -89.97% | -68.25% | -59.86% |
Income Tax Expenses | -106.09% | -93.36% | -80.29% | -61.47% | -55.41% |
Earnings from Continuing Operations | -120.04% | -101.72% | -93.17% | -70.57% | -61.46% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -120.04% | -101.72% | -93.17% | -70.57% | -61.46% |
EBIT | -100.62% | -91.41% | -84.25% | -65.71% | -58.25% |
EBITDA | -87.57% | -81.79% | -76.77% | -60.57% | -53.86% |
EPS Basic | -121.07% | -101.91% | -93.15% | -69.04% | -59.64% |
Normalized Basic EPS | -100.20% | -90.00% | -82.90% | -63.26% | -57.10% |
EPS Diluted | -121.50% | -101.93% | -93.26% | -68.92% | -59.40% |
Normalized Diluted EPS | -100.30% | -90.02% | -82.86% | -63.04% | -56.90% |
Average Basic Shares Outstanding | -5.06% | -4.87% | -4.95% | -5.37% | -5.00% |
Average Diluted Shares Outstanding | -5.61% | -5.45% | -5.53% | -5.90% | -5.48% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |